APA (7th ed.) Citation

Krug, S., Kegel, T., Gress, T. M., Rinke, A., Apostolidis, L., Jann, H., . . . Michl, P. (2021). Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): Study protocol for a multicenter single-arm trial. BMC cancer, 21, . https://doi.org/10.1186/s12885-021-08900-7

Chicago Style (17th ed.) Citation

Krug, Sebastian, et al. "Ramucirumab in Combination with Dacarbazine in Patients with Progressive Well-differentiated Metastatic Pancreatic Neuroendocrine Tumors (RamuNET): Study Protocol for a Multicenter Single-arm Trial." BMC Cancer 21 (2021). https://doi.org/10.1186/s12885-021-08900-7.

MLA (9th ed.) Citation

Krug, Sebastian, et al. "Ramucirumab in Combination with Dacarbazine in Patients with Progressive Well-differentiated Metastatic Pancreatic Neuroendocrine Tumors (RamuNET): Study Protocol for a Multicenter Single-arm Trial." BMC Cancer, vol. 21, 2021, https://doi.org/10.1186/s12885-021-08900-7.